|
KR102110179B1
|
|
Oral disintegrating film containing tadalafil or pharmaceutically acceptable salts thereof as an active ingredient
|
|
KR20180125664A
|
|
Oral dissolving film comprising solifenacin as active ingredients
|
|
KR101537263B1
|
|
A Orally Disintegrating Film masked bitter taste of ondansetron
|
|
KR101538985B1
|
|
Tadalafil Orally Disintegrating Film and Precess For Producing thereof
|
|
WO2015016667A1
|
|
Orally disintegrating film preparation containing donepezil or pharmaceutically acceptable salt thereof, and preparation method therefor
|
|
KR101407922B1
|
|
Porous Orally Disintegrating Film comprising pharmacologically active substance and Precess For Producing thereof
|
|
WO2013129889A2
|
|
High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient
|
|
KR20140052172A
|
|
Fast dissolving film comprising high dose of sildenafil or pharmaceutically acceptable salts thereof
|
|
KR20130110669A
|
|
Pharmaceutical composition comprising branched chain amino acids as active ingredients and the preparation method thereof
|
|
KR20130100037A
|
|
Taste masked pharmaceutical composition comprising sildenafil or pharmaceutically acceptable salts thereof as an active ingredient
|
|
KR20090125660A
|
|
Hmg-coa reductase inhibitor combination formulation
|
|
KR100836960B1
|
|
A novel controlled release-niacin formulation
|
|
KR20060113016A
|
|
Controlled releasable oral administrative composition comprising cetirizine hcl and pseudoephedrine hcl and manufacturing method thereof
|
